Skip to main content
. 2024 May 15;14(6):1649–1657. doi: 10.1007/s13555-024-01182-4

Fig. 3.

Fig. 3

Comparison between phase 3 clinical trials (modified nonresponder imputation analysis) and our real-world experience. PASI Psoriasis Area and Severity Index